The Platelet-Activating Factor Receptor Activates the Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase and Induces Proliferation of Epidermal Cells through an Epidermal Growth Factor-Receptor-Dependent Pathway
Authors:
- Lady C. DyLDLady C. Dy
- Michael D. SouthallMSMichael D. Southall
- Quiaofang YiQYQuiaofang Yi
- Eva SmietanaESEva Smietana
- Reuben KapurRKReuben Kapur
- Mariangela MarquesMMMariangela Marques
- Jeffrey B. TraversJeffrey B. Travers
- Dan F. SpandauDSDan F. Spandau
- 1 March 2002
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 300 (3) , 1026-1035
Abstract
Platelet-activating factor (PAF) is a lipid mediator that has been implicated in a variety of keratinocyte functions. Keratinocytes express the specific receptor for PAF (PAF-R), a seven-transmembrane G-protein-coupled receptor. Although PAF-R-dependent stimulation of numerous signal transduction pathways has been shown in a variety of cell types, to date there has been no analysis of PAF-R signal transduction in human epidermal cells. There is also contradictory evidence that PAF acts as either a suppressor or activator of keratinocyte proliferation. Using a model system created by retroviral-mediated transduction of the PAF-R into the PAF-R-negative epidermal cell line KB, we now demonstrate that the activation of the epidermal PAF-R results in the activation of both the extracellular signal-regulated kinase (ERK) and p38, but not the jun N-terminal kinase mitogen-activated protein (MAP) kinase pathways. Additionally, we show that the activation of the PAF-R stimulates the replication of epidermal cells. The activation of the ERK signal transduction pathway, as well as the PAF-dependent increase in cell proliferation, was dependent on the transactivation of the epidermal growth factor receptor (EGF-R). PAF-R-induced transactivation of the EGF-R was blocked by pharmacologic inhibitors of matrix metalloproteinases, of heparin-binding epidermal growth factor (HB-EGF), and specific inhibitors of the EGF-R tyrosine kinase. Activation of p38 MAP kinase by the PAF-R was not dependent on EGF-R activation and represents a distinct pathway of PAF-R-mediated signal transduction. In summary, these studies provide a mechanism whereby the PAF-R can exert proliferative effects through the activation of the EGF-R.Keywords
This publication has 41 references indexed in Scilit:
- Activation of MAPKs by Angiotensin II in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 2001
- PAF Produced by Human Breast Cancer Cells Promotes Migration and Proliferation of Tumor Cells and Neo-AngiogenesisThe American Journal of Pathology, 2000
- RGS16 Attenuates Gαq-dependent p38 Mitogen-activated Protein Kinase Activation by Platelet-activating FactorJournal of Biological Chemistry, 1999
- Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptorsNature, 1996
- Platelet-activating factor receptor: gene expression and signal transductionBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Release of platelet activating factor (PAF) and eicosanoids in UVC-irradiated corneal stromal cellsCurrent Eye Research, 1995
- Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptorBiochemistry, 1987
- ACCUMULATION OF EOSINOPHILS IN RESPONSE TO INTRACUTANEOUS PAF-ACETHER AND ALLERGENS IN MANThe Lancet, 1986
- Association of Platelet-Activating Factor with Primary Acquired Cold UrticariaNew England Journal of Medicine, 1985
- Structural identification of platelet activating factor in psoriatic scaleBiochemical and Biophysical Research Communications, 1985